Development of a Specific Measure for Assessing Adherence in Adult Patients With Hemophilia.
Development of a Specific Measure for Assessing Adherence in Adult Patients With Hemophilia. The Haemo-Adhaesione Questionnaire
Research project for the development, construction and validation of a questionnaire of adherence to treatment in adult patients with hemophilia. It aims to build a scale according to five relevant dimensions of adherence to treatment: 1) physician-patient relationship, 2) knowledge of the disease, 3) previous bleeding problems, 4) knowledge of future consequences and difficulties, and 5) benefits of treatment.
- Descriptive study for the construction of a multidimensional scale of adherence to treatment in adult patients with hemophilia. - Validation of a scale specific measure for patients with hemophilia that includes 5 dimensions that may affect adherence to treatment: a) the doctor-patient, b) regarding knowledge of the disease, c) the previous hemorrhages, d) knowledge future sequels, e) difficulties with treatment. - Statistical and psychometric analysis of the adherence questionnaire for adult patients with hemophilia. - Description of the theoretical framework that justifies the completion of the questionnaire, and the choice of the dimensions and items that make up the measurement scale. - The questionnaire obtained in this project will identify the actual degree of patient adherence to multidisciplinary treatment, taking as gold standard, compliance with pharmacological treatment (the difference between the treatment prescribed and consumed).
Observational [Patient Registry]
Phase substantive for the creation of a scale
Study Arms / Comparison Groups
Description: Group of patients who we will consult the characteristics of the scale designed and will be made the statistical calculations of validity, reliability and reproducibility
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Primary Completion Date
Inclusion Criteria: - Patients diagnosed with hemophilia A or B. - Patients over 18 years of age. Exclusion Criteria: - Patients with neurological or cognitive impairments that hinder oral and written comprehension. - Patients who have not signed the informed consent document
18 Years - 65 Years
Accepts Healthy Volunteers
Rubén Cuesta-Barriuso, PhD, 868887170, [email protected]
Universidad de Murcia
Rubén Cuesta-Barriuso, PhD, Principal Investigator, Universidad Católica San Antonio